Loading clinical trials...
Loading clinical trials...
The investigators hypothesize that Nigella Sativa will have an effect on Nonalcoholic Steatohepatitis and Liver Steatosis by enhancing lipophagy in the liver tissue.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Hillel Yaffe Medical Center
Hadera, Israel
Start Date
January 1, 2015
Primary Completion Date
January 1, 2017
Completion Date
January 1, 2017
Last Updated
December 4, 2014
100
ESTIMATED participants
Nigella Sativa
DIETARY_SUPPLEMENT
Placebo
DIETARY_SUPPLEMENT
Lead Sponsor
Hillel Yaffe Medical Center
NCT02815891
NCT03587831
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06216041